Home > > > > > Report Detail

Global Acute Myeloid Leukemia Therapeutics Market Insights, Forecast to 2029

Publisher Name :
Date: 14-Aug-2023
No. of pages: 88
Inquire Before Buying

Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age. Incidence rate of acute myeloid leukemia is high in men and women over 50 years.

Market Analysis and Insights: Global Acute Myeloid Leukemia Therapeutics Market

The global Acute Myeloid Leukemia Therapeutics market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Geographically, acute myeloid leukemia therapeutics market is divided into North America, Europe, Asia Pacific, Latin America, and MEA. As of 2014, North America held substantial share of the acute myeloid leukemia therapeutics market owing to prominent growth factors including rising incidences of acute myeloid leukemia and increasing geriatric population. Furthermore, advanced healthcare infrastructure, rising need of targeted therapies, huge investment in the development of pipeline drugs, and awareness amongst the population base induced market growth in this region. Asia Pacific is expected to be the fastest growing region over the forecast period owing to growth factors such as rising investments, rising disposable incomes, increasing cancer awareness, and improving healthcare infrastructure. Additionally, increasing inclination towards therapies such as targeted therapies resulting in low collateral damage and stronger efficacy is also anticipated to propel the demand for the acute myeloid leukemia therapeutics market in this region.

Report Includes

This report presents an overview of global market for Acute Myeloid Leukemia Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Acute Myeloid Leukemia Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Acute Myeloid Leukemia Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Acute Myeloid Leukemia Therapeutics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Acute Myeloid Leukemia Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Acute Myeloid Leukemia Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Ambit Biosciences Corporation, Genzyme Corporation Celgene Corporation, Clavis Pharma ASA, Sunesis Pharmaceuticals, Cephalon, Bristol-Myers Squibb, Novartis International AG and GlaxoSmithKline, etc.

By Company

- Ambit Biosciences Corporation

- Genzyme Corporation Celgene Corporation

- Clavis Pharma ASA

- Sunesis Pharmaceuticals

- Cephalon

- Bristol-Myers Squibb

- Novartis International AG

- GlaxoSmithKline

Segment by Type

- Pipeline Drugs

- Chemotherapy Drugs

- Chemotherapy Regimens

Segment by Application

- Hospitals

- Clinics

- Home Care

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Acute Myeloid Leukemia Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Acute Myeloid Leukemia Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acute Myeloid Leukemia Therapeutics revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Acute Myeloid Leukemia Therapeutics Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Pipeline Drugs
1.2.3 Chemotherapy Drugs
1.2.4 Chemotherapy Regimens
1.3 Market by Application
1.3.1 Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Myeloid Leukemia Therapeutics Market Perspective (2018-2029)
2.2 Global Acute Myeloid Leukemia Therapeutics Growth Trends by Region
2.2.1 Acute Myeloid Leukemia Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Acute Myeloid Leukemia Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Acute Myeloid Leukemia Therapeutics Market Dynamics
2.3.1 Acute Myeloid Leukemia Therapeutics Industry Trends
2.3.2 Acute Myeloid Leukemia Therapeutics Market Drivers
2.3.3 Acute Myeloid Leukemia Therapeutics Market Challenges
2.3.4 Acute Myeloid Leukemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Acute Myeloid Leukemia Therapeutics by Players
3.1.1 Global Acute Myeloid Leukemia Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Acute Myeloid Leukemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Acute Myeloid Leukemia Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Acute Myeloid Leukemia Therapeutics Market Concentration Ratio
3.4.1 Global Acute Myeloid Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Therapeutics Revenue in 2022
3.5 Global Key Players of Acute Myeloid Leukemia Therapeutics Head office and Area Served
3.6 Global Key Players of Acute Myeloid Leukemia Therapeutics, Product and Application
3.7 Global Key Players of Acute Myeloid Leukemia Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Myeloid Leukemia Therapeutics Breakdown Data by Type
4.1 Global Acute Myeloid Leukemia Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Type (2024-2029)
5 Acute Myeloid Leukemia Therapeutics Breakdown Data by Application
5.1 Global Acute Myeloid Leukemia Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Acute Myeloid Leukemia Therapeutics Market Size (2018-2029)
6.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Type
6.2.1 North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2024-2029)
6.2.3 North America Acute Myeloid Leukemia Therapeutics Market Share by Type (2018-2029)
6.3 North America Acute Myeloid Leukemia Therapeutics Market Size by Application
6.3.1 North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2024-2029)
6.3.3 North America Acute Myeloid Leukemia Therapeutics Market Share by Application (2018-2029)
6.4 North America Acute Myeloid Leukemia Therapeutics Market Size by Country
6.4.1 North America Acute Myeloid Leukemia Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Acute Myeloid Leukemia Therapeutics Market Size (2018-2029)
7.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type
7.2.1 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2024-2029)
7.2.3 Europe Acute Myeloid Leukemia Therapeutics Market Share by Type (2018-2029)
7.3 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application
7.3.1 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2024-2029)
7.3.3 Europe Acute Myeloid Leukemia Therapeutics Market Share by Application (2018-2029)
7.4 Europe Acute Myeloid Leukemia Therapeutics Market Size by Country
7.4.1 Europe Acute Myeloid Leukemia Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Acute Myeloid Leukemia Therapeutics Market Size (2018-2029)
8.2 China Acute Myeloid Leukemia Therapeutics Market Size by Type
8.2.1 China Acute Myeloid Leukemia Therapeutics Market Size by Type (2018-2023)
8.2.2 China Acute Myeloid Leukemia Therapeutics Market Size by Type (2024-2029)
8.2.3 China Acute Myeloid Leukemia Therapeutics Market Share by Type (2018-2029)
8.3 China Acute Myeloid Leukemia Therapeutics Market Size by Application
8.3.1 China Acute Myeloid Leukemia Therapeutics Market Size by Application (2018-2023)
8.3.2 China Acute Myeloid Leukemia Therapeutics Market Size by Application (2024-2029)
8.3.3 China Acute Myeloid Leukemia Therapeutics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Acute Myeloid Leukemia Therapeutics Market Size (2018-2029)
9.2 Asia Acute Myeloid Leukemia Therapeutics Market Size by Type
9.2.1 Asia Acute Myeloid Leukemia Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Acute Myeloid Leukemia Therapeutics Market Size by Type (2024-2029)
9.2.3 Asia Acute Myeloid Leukemia Therapeutics Market Share by Type (2018-2029)
9.3 Asia Acute Myeloid Leukemia Therapeutics Market Size by Application
9.3.1 Asia Acute Myeloid Leukemia Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Acute Myeloid Leukemia Therapeutics Market Size by Application (2024-2029)
9.3.3 Asia Acute Myeloid Leukemia Therapeutics Market Share by Application (2018-2029)
9.4 Asia Acute Myeloid Leukemia Therapeutics Market Size by Region
9.4.1 Asia Acute Myeloid Leukemia Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Acute Myeloid Leukemia Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Acute Myeloid Leukemia Therapeutics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Ambit Biosciences Corporation
11.1.1 Ambit Biosciences Corporation Company Details
11.1.2 Ambit Biosciences Corporation Business Overview
11.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Introduction
11.1.4 Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
11.1.5 Ambit Biosciences Corporation Recent Developments
11.2 Genzyme Corporation Celgene Corporation
11.2.1 Genzyme Corporation Celgene Corporation Company Details
11.2.2 Genzyme Corporation Celgene Corporation Business Overview
11.2.3 Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Introduction
11.2.4 Genzyme Corporation Celgene Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
11.2.5 Genzyme Corporation Celgene Corporation Recent Developments
11.3 Clavis Pharma ASA
11.3.1 Clavis Pharma ASA Company Details
11.3.2 Clavis Pharma ASA Business Overview
11.3.3 Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Introduction
11.3.4 Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
11.3.5 Clavis Pharma ASA Recent Developments
11.4 Sunesis Pharmaceuticals
11.4.1 Sunesis Pharmaceuticals Company Details
11.4.2 Sunesis Pharmaceuticals Business Overview
11.4.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Introduction
11.4.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
11.4.5 Sunesis Pharmaceuticals Recent Developments
11.5 Cephalon
11.5.1 Cephalon Company Details
11.5.2 Cephalon Business Overview
11.5.3 Cephalon Acute Myeloid Leukemia Therapeutics Introduction
11.5.4 Cephalon Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
11.5.5 Cephalon Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Introduction
11.6.4 Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Novartis International AG
11.7.1 Novartis International AG Company Details
11.7.2 Novartis International AG Business Overview
11.7.3 Novartis International AG Acute Myeloid Leukemia Therapeutics Introduction
11.7.4 Novartis International AG Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
11.7.5 Novartis International AG Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Introduction
11.8.4 GlaxoSmithKline Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
11.8.5 GlaxoSmithKline Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Pipeline Drugs
Table 3. Key Players of Chemotherapy Drugs
Table 4. Key Players of Chemotherapy Regimens
Table 5. Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Acute Myeloid Leukemia Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Acute Myeloid Leukemia Therapeutics Market Share by Region (2018-2023)
Table 9. Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Acute Myeloid Leukemia Therapeutics Market Share by Region (2024-2029)
Table 11. Acute Myeloid Leukemia Therapeutics Market Trends
Table 12. Acute Myeloid Leukemia Therapeutics Market Drivers
Table 13. Acute Myeloid Leukemia Therapeutics Market Challenges
Table 14. Acute Myeloid Leukemia Therapeutics Market Restraints
Table 15. Global Acute Myeloid Leukemia Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Acute Myeloid Leukemia Therapeutics Revenue Share by Players (2018-2023)
Table 17. Global Top Acute Myeloid Leukemia Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia Therapeutics as of 2022)
Table 18. Global Acute Myeloid Leukemia Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Acute Myeloid Leukemia Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Acute Myeloid Leukemia Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Acute Myeloid Leukemia Therapeutics, Product and Application
Table 22. Global Key Players of Acute Myeloid Leukemia Therapeutics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Myeloid Leukemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2024-2029)
Table 28. Global Acute Myeloid Leukemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Acute Myeloid Leukemia Therapeutics Revenue Share by Application (2018-2023)
Table 30. Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Acute Myeloid Leukemia Therapeutics Revenue Share by Application (2024-2029)
Table 32. North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Acute Myeloid Leukemia Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Acute Myeloid Leukemia Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Acute Myeloid Leukemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Acute Myeloid Leukemia Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Acute Myeloid Leukemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Acute Myeloid Leukemia Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Acute Myeloid Leukemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Acute Myeloid Leukemia Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Acute Myeloid Leukemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Acute Myeloid Leukemia Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Acute Myeloid Leukemia Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Acute Myeloid Leukemia Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Acute Myeloid Leukemia Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 64. Ambit Biosciences Corporation Company Details
Table 65. Ambit Biosciences Corporation Business Overview
Table 66. Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Product
Table 67. Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 68. Ambit Biosciences Corporation Recent Developments
Table 69. Genzyme Corporation Celgene Corporation Company Details
Table 70. Genzyme Corporation Celgene Corporation Business Overview
Table 71. Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Product
Table 72. Genzyme Corporation Celgene Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 73. Genzyme Corporation Celgene Corporation Recent Developments
Table 74. Clavis Pharma ASA Company Details
Table 75. Clavis Pharma ASA Business Overview
Table 76. Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Product
Table 77. Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 78. Clavis Pharma ASA Recent Developments
Table 79. Sunesis Pharmaceuticals Company Details
Table 80. Sunesis Pharmaceuticals Business Overview
Table 81. Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Product
Table 82. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 83. Sunesis Pharmaceuticals Recent Developments
Table 84. Cephalon Company Details
Table 85. Cephalon Business Overview
Table 86. Cephalon Acute Myeloid Leukemia Therapeutics Product
Table 87. Cephalon Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 88. Cephalon Recent Developments
Table 89. Bristol-Myers Squibb Company Details
Table 90. Bristol-Myers Squibb Business Overview
Table 91. Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Product
Table 92. Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 93. Bristol-Myers Squibb Recent Developments
Table 94. Novartis International AG Company Details
Table 95. Novartis International AG Business Overview
Table 96. Novartis International AG Acute Myeloid Leukemia Therapeutics Product
Table 97. Novartis International AG Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 98. Novartis International AG Recent Developments
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Product
Table 102. GlaxoSmithKline Revenue in Acute Myeloid Leukemia Therapeutics Business (2018-2023) & (US$ Million)
Table 103. GlaxoSmithKline Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Acute Myeloid Leukemia Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Pipeline Drugs Features
Figure 4. Chemotherapy Drugs Features
Figure 5. Chemotherapy Regimens Features
Figure 6. Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Acute Myeloid Leukemia Therapeutics Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Home Care Case Studies
Figure 11. Acute Myeloid Leukemia Therapeutics Report Years Considered
Figure 12. Global Acute Myeloid Leukemia Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Acute Myeloid Leukemia Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Acute Myeloid Leukemia Therapeutics Market Share by Region: 2022 VS 2029
Figure 15. Global Acute Myeloid Leukemia Therapeutics Market Share by Players in 2022
Figure 16. Global Top Acute Myeloid Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia Therapeutics Revenue in 2022
Figure 18. North America Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Acute Myeloid Leukemia Therapeutics Market Share by Type (2018-2029)
Figure 20. North America Acute Myeloid Leukemia Therapeutics Market Share by Application (2018-2029)
Figure 21. North America Acute Myeloid Leukemia Therapeutics Market Share by Country (2018-2029)
Figure 22. United States Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Acute Myeloid Leukemia Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Acute Myeloid Leukemia Therapeutics Market Share by Type (2018-2029)
Figure 26. Europe Acute Myeloid Leukemia Therapeutics Market Share by Application (2018-2029)
Figure 27. Europe Acute Myeloid Leukemia Therapeutics Market Share by Country (2018-2029)
Figure 28. Germany Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Acute Myeloid Leukemia Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Acute Myeloid Leukemia Therapeutics Market Share by Type (2018-2029)
Figure 36. China Acute Myeloid Leukemia Therapeutics Market Share by Application (2018-2029)
Figure 37. Asia Acute Myeloid Leukemia Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Acute Myeloid Leukemia Therapeutics Market Share by Type (2018-2029)
Figure 39. Asia Acute Myeloid Leukemia Therapeutics Market Share by Application (2018-2029)
Figure 40. Asia Acute Myeloid Leukemia Therapeutics Market Share by Region (2018-2029)
Figure 41. Japan Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Acute Myeloid Leukemia Therapeutics Market Share by Country (2018-2029)
Figure 51. Brazil Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Ambit Biosciences Corporation Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
Figure 58. Genzyme Corporation Celgene Corporation Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
Figure 59. Clavis Pharma ASA Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
Figure 60. Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
Figure 61. Cephalon Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
Figure 63. Novartis International AG Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global Cancer Immunomodulator Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......
  • Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......
  • Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......
  • Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125
    According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......
  • Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......
  • Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......
  • T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85
    CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......
  • Global Kaposi Sarcoma Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107
    Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......
  • Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs